Recombinant Human Thrombopoietin Injection.
Recombinant human thrombopoietin, Human serum albumin, NaCl
Colorless and transparent liquid without any macroscopic insoluble substance.
7500U/1ml or 15000 U/1ml
Store at 2oC-8oC. Avoid direct sunlight.
1 vial, 1ml/vial.
The shelf life of the drug is three years from the date of manufacture.
TPIAO (Thrombopoietin)TPIAO 15,000U/mL
(Recombinant Human Thrombopoietin Injection)
rhTPO is suitable for the thrombocytopenia associated with chemotherapy in cancer patients with solid tumour. rhTPO therapy is recommended to patients with the platelet levels lower than 50×109/L or in cases which the doctor find it necessary to increase the patient's platelet level.
The safety of TPO therapy in pregnant women has not been established. Because many drugs are excreted in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Shenyang Sunshine Pharmaceutical Co., Ltd.
No. 3 A1, 10th Road,
Shenyang Economy & Technology
Development Zone, Shenyang 110027, P.R. China
Exclusively Imported By
Goodfellow Pharma Corporation
Unit 3009 Jollibee Plaza Bldg., Emerald Ave.,
Ortigas Center, Pasig City
Tel. Nos.: (632) 632-7031
Fax: (632) 635-3957
Copyright © 2008 Goodfellow Pharma Corporation
Unit 3009 Jollibee Plaza Bldg.,
Emerald Ave., Ortigas Center 1605 Pasig City
Telephone: (+632) 635-3957 / 632-7031
Mobile No.: (0917) 831-1338